INDEX VALUES   |

Home > Our Indexes > LSCIBC

Download Methodology

LifeSci Biotechnology Clinical Trials Index


The LifeSci Biotechnology Clinical Trials Index ("LSCIBC") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development. The inception date for LSCIBC was November 3, 2014.

LSCIBCS&P 500
Prior Day Closing Value3732.524778.07
Prior Day Change %-1.87%+1.93%
Current Value
Current Day Change %-0.89%-1.71%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Jul 01, 2017)


No. of Constituents 74
Total Market Cap ($ in millions) 91,285
Mean Market Cap ($ in millions) 1,234
Median Market Cap ($ in millions) 665
Largest Constituent ($ in millions) 7,120
Smallest Constituent ($ in millions) 242

Market Cap Breakdown (Jul 01, 2017)


Top 10 Constituents (Jul 01, 2017)


Constituent Ticker Weight
Portola Pharmaceuticals Inc PTLA 1.90%
Immunogen Inc IMGN 1.79%
Beigene Ltd-adr BGNE 1.70%
Blueprint Medicines Corp BPMC 1.63%
Arena Pharmaceuticals Inc ARNA 1.60%
Esperion Therapeutics Inc ESPR 1.60%
Juno Therapeutics Inc JUNO 1.56%
Dynavax Technologies Corp DVAX 1.56%
Epizyme Inc EPZM 1.56%
Reata Pharmaceuticals Inc-a RETA 1.55%
Data Updated Monthly
Download All Constituents